■今天,多发性硬化症(MS)患者的生活质量通常是通过一个人的整体生活质量来衡量的,而不是局限于复发或残疾进展频率降低的更传统指标.这种焦点的变化,更全面的健康观,比如整体生活质量,改变了提供者和多发性硬化症患者对与MS生活在一起至关重要的看法。
■这篇叙述性综述旨在研究有关现有和新兴的非药物干预措施的相关文献,这些干预措施可改善所有健康领域的多发性硬化症患者的生活质量。
■在MEDLINE上进行了文献检索,CINAHL,和Scopus电子数据库使用以下搜索词:生活质量,与健康相关的生活质量,生活质量,生活满意度,非药物干预,非药物,和干预。筛选摘要后,本综述选择了24名。
■常见的非药物干预措施用于疲劳和睡眠,精神和情绪健康,认知,身体健康,和慢性疼痛。本综述中包含的几种非药物干预措施积极改善了多发性硬化症患者的整体生活质量。这些干预措施包括锻炼,认知行为疗法,和认知康复。
■运动和认知行为疗法等非药物干预措施可改善MS患者的生活质量。这些干预措施应在常规医疗期间进行更多规定。将这项研究转化为标准的临床实践应该是一个重点领域。此外,更高质量的研究,如随机对照试验,需要对新兴的非药物干预措施进行评估。
UNASSIGNED: Today, living well with multiple sclerosis (MS) is often measured by a person\'s overall quality of life rather than being limited to the more traditional metrics of reduced frequency of relapses or progression of disability. This change in focus, to a more holistic view of health, such as overall quality of life, has shifted the views of what both providers and people with multiple sclerosis view as essential for living well with MS.
UNASSIGNED: This narrative review aims to examine the relevant literature on existing and emerging non-pharmacological interventions shown to improve the quality of life for people with multiple sclerosis across all health domains.
UNASSIGNED: A literature search was conducted on MEDLINE, CINAHL, and Scopus electronic databases using the following search terms: quality of life, health-related quality of life, life quality, life satisfaction, non-pharmacological intervention, non-drug, and intervention. After screening the abstracts, 24 were selected for this review.
UNASSIGNED: Common non-pharmacological interventions were used for fatigue and sleep, mental and emotional health, cognition, physical health, and chronic pain. Several non-pharmacological interventions included in this review positively improved the overall quality of life for people with multiple sclerosis. These interventions included exercise, cognitive behavior therapy, and cognitive rehabilitation.
UNASSIGNED: Non-pharmacological interventions such as exercise and cognitive behavioral therapy improve the quality of life for people with MS. These interventions should be prescribed more during routine medical care. Translating this research into standard clinical practice should be one area of focus. In addition, higher quality studies, such as randomized control trials, need to be conducted on emerging nonpharmacological interventions to assess effectiveness.